FDA Approved: GLATIRAMER ACETATE — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves Mylan's original application (ANDA) for glatiramer acetate, a generic version of Copaxone, for the treatment of multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• GLATIRAMER ACETATE (GLATIRAMER ACETATE)

Snippet

ORIG AP for GLATIRAMER ACETATE (GLATIRAMER ACETATE)